Belite Bio, Inc: chief medical officer Hendrik Peter Scholl sold 500 shares

What happened Hendrik Peter Scholl, chief medical officer, sold 500 American depositary shares in open-market transactions on Oct 1, 2026. The filing lists eight sales: 200 shares at $163.63 for $32,725; 24 shares at $164.64 for $3,951; 120 shares at $165.49 for $19,859; 50 shares at $166.44 for $8,322; 78 shares at $167.59 for $13,072; 12 shares at $168.21 for $2,019; 14 shares at $169.36 for $2,371; and 2 shares at $170.02 for $340, totaling $82,659.

Key details

• Transaction date: Oct 1, 2026. Form filed Oct 5, 2026.
• Trades: 8 open-market sales totaling 500 shares at prices from $163.63 to $170.02; total proceeds $82,659.
• Shares owned after the transaction: not reported in this Form 4.
• Footnotes: F1 states each American depositary share represents one ordinary share; F2 states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted on Jun 25, 2026; F3–F9 describe weighted-average price ranges for groups of shares and offer to provide per-price details upon request.

Why it may matter

• The filing shows open-market sales and does not report an option exercise, cashless exercise, or a gift.
• The filing identifies Scholl as the chief medical officer; it does not indicate 10% owner status. A filing does not show why the insider traded or why the company acted.